INJECTAFER: payments to doctors
Payments that named INJECTAFER as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $7.6M
- Providers
- 48,781
- Transactions
- 169,086
- Average per transaction
- $45
The per-transaction average — $45 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 48,781 providers the average total is $155, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Daiichi Sankyo Inc. | $7,044,903 | 93.2% |
| American Regent | $513,689 | 6.8% |